ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
When do Orphenadrine Citrate, Aspirin, And Caffeine patents expire, and what generic alternatives are available?
Orphenadrine Citrate, Aspirin, And Caffeine is a drug marketed by Sandoz and Stevens J and is included in two NDAs.
The generic ingredient in ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE?
- What are the global sales for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE?
- What is Average Wholesale Price for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE?
Summary for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE at DailyMed |
US Patents and Regulatory Information for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 074654-001 | Dec 31, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Stevens J | ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 074988-002 | Apr 30, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 074654-002 | Dec 31, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
